Does MYCOPHENOLATE MOFETIL Cause Type v hyperlipidaemia? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Type v hyperlipidaemia have been filed in association with MYCOPHENOLATE MOFETIL (Mycophenolate mofetil). This represents 0.0% of all adverse event reports for MYCOPHENOLATE MOFETIL.
10
Reports of Type v hyperlipidaemia with MYCOPHENOLATE MOFETIL
0.0%
of all MYCOPHENOLATE MOFETIL reports
0
Deaths
7
Hospitalizations
How Dangerous Is Type v hyperlipidaemia From MYCOPHENOLATE MOFETIL?
Of the 10 reports, 7 (70.0%) required hospitalization.
Is Type v hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLATE MOFETIL. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLATE MOFETIL Cause?
Off label use (13,474)
Drug ineffective (7,729)
Product use in unapproved indication (5,910)
Diarrhoea (3,628)
Cytomegalovirus infection (3,278)
Pneumonia (3,017)
Pyrexia (2,927)
Condition aggravated (2,883)
Covid-19 (2,706)
Transplant rejection (2,500)
What Other Drugs Cause Type v hyperlipidaemia?
SACUBITRIL\VALSARTAN (25)
ASPIRIN (24)
CARVEDILOL (23)
ATORVASTATIN (22)
RAMIPRIL (22)
ALENDRONATE (21)
DAPAGLIFLOZIN (21)
ALLOPURINOL (19)
EPLERENONE (19)
EZETIMIBE (19)
Which MYCOPHENOLATE MOFETIL Alternatives Have Lower Type v hyperlipidaemia Risk?
MYCOPHENOLATE MOFETIL vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL vs MYCOPHENOLIC ACID
MYCOPHENOLATE MOFETIL vs MYFORTIC
MYCOPHENOLATE MOFETIL vs MYRBETRIQ
MYCOPHENOLATE MOFETIL vs NABILONE